Check Out Trxade Health Inc (MEDS)’s Trade Data Rather Than the Analysts’ Views

With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.39 million shares. The 52-week range on MEDS shows that it touched its highest point at $21.22 and its lowest point at $3.69 during that stretch. It currently has a 1-year price target of $6.75. Beta for the stock currently stands at 1.86.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MEDS was up-trending over the past week, with a rise of 99.58%, but this was up by 346.65% over a month. Three-month performance surged to 208.94% while six-month performance rose 75.12%. The stock gained 208.94% in the past year, while it has gained 265.64% so far this year.

Float and Shares Shorts:

At present, 1.21 million MEDS shares are outstanding with a float of 0.85 million shares on hand for trading. On Feb 15, 2024, short shares totaled 11390.0, which was 0.95% higher than short shares on Jan 12, 2024. In addition to MEMS as the firm’s MATTHEWS EMERGING MARKETS DISCO, MEDS serves as its TRxADE HEALTH, Inc.

Institutional Ownership:

Through their ownership of 5.66% of MEDS’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MEDS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, MEDS has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and MEDS currently yields $0.00. In the past year, MEDS’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, MEDS has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.